Adavosertib and Gemcitabine in Advanced Pancreatic

NCT05212025 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped manufacturer choice

Conditions

Pancreatic Cancer

Interventions

DRUG: Adavosertib
DRUG: Gemcitabine

Sponsor

James Cleary, MD, PhD

Collaborators

[object Object]
[object Object]
[object Object]